Neuberg Diagnostics, Sehgal Path Lab Forge Strategic Partnership to Elevate Haemato-Oncology Segment

Written by Arushi Sharma

Neuberg Diagnostics and Sehgal Path Lab join forces to enhance Haemato-Oncology services, marking a significant advancement in Indian healthcare. Driven by innovation and collaboration, the partnership promises unparalleled diagnostic solutions for patients nationwide.

Neuberg Diagnostics, Sehgal Path Lab Forge Strategic Partnership to Elevate Haemato-Oncology Segment
Neuberg Diagnostics partners with Sehgal Path Lab, aiming to elevate Haemato-Oncology services in India.

Neuberg Diagnostics has embarked on a strategic joint venture with Sehgal Path Lab, aimed at bolstering the Haemato-Oncology segment and enhancing diagnostic services in India.

Under this collaboration, Sehgal Path Lab will be rebranded as Neuberg Sehgal Path Lab in the near future, with Dr. Kunal Sehgal, a nationally acclaimed haematopathologist, continuing to lead as the Managing Director and Chief Pathologist of the joint venture.

Dr. GSK Velu, Chairman and Managing Director of Neuberg Diagnostics, expressed his satisfaction with the partnership, stating, "I am pleased to partner with Dr. Kunal Sehgal, a renowned haematopathologist in India. Through strategic collaborations and ongoing innovation, Neuberg Diagnostics is committed to delivering unparalleled diagnostic services that positively impact patient outcomes and healthcare delivery."

With a significant presence in Maharashtra, including four entities in Mumbai and AG Diagnostics, a Neuberg subsidiary, in Pune, Dr. Velu highlighted the consolidation of Neuberg's leadership position in Karnataka, Gujarat, Tamil Nadu, and Madhya Pradesh. He affirmed Neuberg's dedication to investing in Maharashtra, aiming to establish itself as one of the premier diagnostics chains in the state within the next two years.

Dr. Kunal Sehgal echoed the sentiment of collaboration, expressing excitement about partnering with Neuberg Diagnostics, a global leader in diagnostics innovation. He emphasized the joint venture's goal of providing patients with unparalleled access to routine and specialized tests, including advanced genetic and oncology services, all under one roof.
Furthermore, Dr. Sehgal outlined plans to expand research and education initiatives, training programs, and collaborations with educational institutions and research organizations. He emphasized his vision of developing Haematopathology as a field in the country, leveraging the resources and expertise of both Neuberg Diagnostics and Sehgal Path Lab.

The partnership between Neuberg Diagnostics and Sehgal Path Lab signifies a significant advancement in the diagnostic healthcare landscape, with a focus on elevating Haemato-Oncology services and enhancing patient care across India.

Share article